Groove Biopharma Corp — Form D
Groove Biopharma Corp of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-28. $3.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2010-04-28
- Form: D
- Accession: 0001443563-10-000002
- Industry: Other Health Care
- Exemptions: 06
- Amount sold: $3.9M
- Investors: 7
- Date of first sale: 2010-04-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-141242
Issuer
- Name: Groove Biopharma Corp
- CIK: 0001443563
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 1616 Eastlake Avenue E., Suite 202, Seattle, WA, 98102
- Phone: 206-957-7300
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Steven Gillis | Director | South San Francisco, CA |
| Chad Waite | Director | SEATTLE, WA |
| THONG LE | Director | Seattle, WA |
| LINDSAY RAYLE | Executive Officer | New York, NY |
| Brian Atwood | Director | South San Francisco, CA |
| David Schubert | Executive Officer | New York, NY |
| Carl Weissman | Director | San Diego, CA |
| Carl Weissman | Executive Officer | San Diego, CA |
| Merl F Hoekstra | Director | Bothell, WA |
Other filings by this issuer (1)
More